Press releases

Dr. Pierre-André Wicker joins Pharmaleads’ Board of Directors

A prominent specialist in drug development, he will accompany Pharmaleads through the next clinical development stages of PL37, the Company’s first molecule aimed at treating neuropathic pain Paris, July the 2nd 2015 – Pharmaleads, a company specialising in the discovery and early-stage development of small molecule inhibitors of metalloproteases for the treatment of severe pain, […] Read full post »

Pharmaleads announces the inclusion of the first patient in Phase IIa study of oral PL37 for pain in diabetic neuropathy

Pharmaleads announces the inclusion of the first patient in Phase IIa study of oral PL37 for pain in diabetic neuropathy World premiere for Dual Enkephalinase Inhibitors (DENKIs), a new class of analgesics and first novel concept for decades in the treatment of chronic pain. Paris, 22 April 2015 – Pharmaleads, a company specialising in the […] Read full post »

Pharmaleads and Debiopharm sign licence agreement

Lausanne, Switzerland, and Paris, France, November 17, 2008. Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Pharmaleads SAS, a science driven drug discovery and early development company, today announced the signature of an exclusive license agreement for the development, registration and commercialisation of a small molecule […] Read full post »

Page 2 of 212
Discover our publications
NEWS RELEASES